98 related articles for article (PubMed ID: 10348244)
1. Relationships between several markers of extracellular matrix turn-over and ultrasonography in human Schistosomiasis mansoni.
Ricard-Blum S; Hartmann DJ; Grenard P; Ravaoalimalala VE; Boisier P; Esterre P
Am J Trop Med Hyg; 1999 Apr; 60(4):658-63. PubMed ID: 10348244
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of connective tissue metabolites in Schistosoma mansoni related liver disease.
Kardorff R; Mugashe C; Gabone RM; Mahlert C; Doehring E
Acta Trop; 1999 Jul; 73(2):153-64. PubMed ID: 10465055
[TBL] [Abstract][Full Text] [Related]
3. Changes of ultrasonography and two serum biochemical indices for hepatic fibrosis in schistosomiasis japonica patients one year after praziquantel treatment.
Cai W; Chen Z; Chen F; Zhou C; Liu R; Wang J
Chin Med J (Engl); 1997 Oct; 110(10):797-800. PubMed ID: 9642313
[TBL] [Abstract][Full Text] [Related]
4. Potential use of collagen and elastin degradation markers for monitoring liver fibrosis in schistosomiasis.
Stone PJ
Acta Trop; 2000 Oct; 77(1):97-9. PubMed ID: 10996125
[TBL] [Abstract][Full Text] [Related]
5. Effect of early treatment with praziquantel on serum connective tissue metabolite markers in children and adolescents with intestinal schistosomiasis mansoni.
Hassanein HI; Zoheiry MM; Voss B; el Attar GM; Hassan SI; Demerdash ZA; el Baz HM; Yousif OA
Arzneimittelforschung; 1997 Jan; 47(1):84-7. PubMed ID: 9037450
[TBL] [Abstract][Full Text] [Related]
6. Schistosoma mansoni infection in a recently exposed community in Senegal: lack of correlation between liver morphology in ultrasound and connective tissue metabolites in serum.
Burchard GD; Guissé-Sow F; Diop M; Ly A; Lanuit R; Gryseels B; Gressner AM
Trop Med Int Health; 1998 Mar; 3(3):234-41. PubMed ID: 9593363
[TBL] [Abstract][Full Text] [Related]
7. Serum hyaluronan and collagen IV as non-invasive markers of liver fibrosis in patients from an endemic area for schistosomiasis mansoni: a field-based study in Brazil.
Marinho CC; Bretas T; Voieta I; Queiroz LC; Ruiz-Guevara R; Teixeira AL; Antunes CM; Prata A; Lambertucci JR
Mem Inst Oswaldo Cruz; 2010 Jul; 105(4):471-8. PubMed ID: 20721493
[TBL] [Abstract][Full Text] [Related]
8. Serum concentrations of sICAM-1, sE-, sP- and sL-selectins in patients with Schistosoma mansoni infection and association with disease severity.
Esterre P; Raobelison A; Ramarokoto CE; Ravaoalimalala VE; Boisier P; Roux J
Parasite Immunol; 1998 Aug; 20(8):369-76. PubMed ID: 9767602
[TBL] [Abstract][Full Text] [Related]
9. The use of pentoxifylline as adjuvant therapy with praziquantel downregulates profibrogenic cytokines, collagen deposition and oxidative stress in experimental schistosomiasis mansoni.
El-Lakkany N; el-Din SS; Ebeid F
Exp Parasitol; 2011 Oct; 129(2):152-7. PubMed ID: 21762692
[TBL] [Abstract][Full Text] [Related]
10. Schistosomiasis mansoni: ultrasound-evaluated hepatic fibrosis and serum concentrations of hyaluronic acid.
Silva CC; Domingues AL; Lopes EP; Morais CN; Santos RB; Luna CF; Nader HB; Martins JR
Ann Trop Med Parasitol; 2011 Apr; 105(3):233-9. PubMed ID: 21801502
[TBL] [Abstract][Full Text] [Related]
11. Serum procollagen peptides and collagen type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease.
Shahin M; Schuppan D; Waldherr R; Risteli J; Risteli L; Savolainen ER; Oesterling C; Abdel Rahman HM; el Sahly AM; Abdel Razek SM
Hepatology; 1992 Apr; 15(4):637-44. PubMed ID: 1551641
[TBL] [Abstract][Full Text] [Related]
12. Morphological features of collagen degradation in advanced hepatic schistosomiasis of man.
Andrade ZA
Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():129-38. PubMed ID: 1343883
[TBL] [Abstract][Full Text] [Related]
13. Circulating adhesion molecules in patients with different clinical forms of S. mansoni infection.
Talaat RM; El-Bassiouny A; Osman A; Yossif M; Charmy R; Al-Sherbiny M
Egypt J Immunol; 2005; 12(2):143-54. PubMed ID: 17977219
[TBL] [Abstract][Full Text] [Related]
14. Hepatic fibrosis: are any of the serum markers useful?
Oh S; Afdhal NH
Curr Gastroenterol Rep; 2001 Feb; 3(1):12-8. PubMed ID: 11177689
[TBL] [Abstract][Full Text] [Related]
15. Liver involvement in human schistosomiasis mansoni. Regression of immunological and biochemical disease markers after specific treatment.
Zwingenberger K; Harms G; Feldmeier H; Müller O; Steiner A; Bienzle U
Acta Trop; 1988 Sep; 45(3):263-75. PubMed ID: 2903628
[TBL] [Abstract][Full Text] [Related]
16. Hepatosplenic schistosomiasis is characterised by high blood markers of translocation, inflammation and fibrosis.
Sinkala E; Kapulu MC; Besa E; Zyambo K; Chisoso NJ; Foster GR; Kelly P
Liver Int; 2016 Jan; 36(1):145-50. PubMed ID: 26058680
[TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of the collagen cross-link pyridinoline increases during liver fibrogenesis.
Grenard P; Blanquier B; Ricard-Blum S
J Hepatol; 1997 Jun; 26(6):1356-62. PubMed ID: 9210624
[TBL] [Abstract][Full Text] [Related]
18. Praziquantel in the treatment of hepatosplenic schistosomiasis: biochemical disease markers indicate deceleration of fibrogenesis and diminution of portal flow obstruction.
Zwingenberger K; Richter J; Vergetti JG; Feldmeier H
Trans R Soc Trop Med Hyg; 1990; 84(2):252-6. PubMed ID: 2117787
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of extracellular matrix in acute pancreatitis.
Löhr M; Hummel F; Martus P; Cidlinsky K; Kröger JC; Hahn EG; Oesterling C; Emmrich J; Schuppan D; Liebe S
Hepatogastroenterology; 1999; 46(30):3263-70. PubMed ID: 10626198
[TBL] [Abstract][Full Text] [Related]
20. Effect of combined chemotherapy and anti-inflammatory drugs on murine schistosomiasis.
Mahmoud MR; Zoheiry MM; Nosseir MM
Arzneimittelforschung; 2002; 52(4):294-301. PubMed ID: 12040972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
